Subscribe
shutterstock_685347493_katherine_welles
Katherine Welles / Shutterstock.com
7 August 2020AmericasSarah Morgan

BMS, Pfizer secure victory over generic makers

In a victory for  Bristol-Myers Squibb (BMS) and  Pfizer, a US federal judge has affirmed patents covering blood-thinner Eliquis (apixaban).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
BMS, Pfizer win patent dispute over blockbuster drug, Eliquis
6 September 2021   In a victory for Bristol-Myers Squibb and Pfizer, the US Court of Appeals for the Federal Circuit has affirmed the validity of a pair of patents covering blood clot treatment, Eliquis.
Biotechnology
Pfizer to collaborate with Imcyse on new immunotherapy programme
5 February 2021   Pfizer has struck a research and licensing agreement with Belgium biopharmaceutical company Imcyse to develop treatments for rheumatoid arthritis using Imotopes - Imcyse’s platform of immunotherapeutics based on synthetic peptides.
Generics
Sigmapharm to appeal Pfizer and BMS’ Eliquis win
3 September 2020   Generics maker Sigmapharm Laboratories is appealing against a court win for Pfizer and Bristol Myers Squibb over patents for blood-thinner Eliquis.


Editor's picks

BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

Editor's picks

Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More on this story

Americas
BMS, Pfizer win patent dispute over blockbuster drug, Eliquis
6 September 2021   In a victory for Bristol-Myers Squibb and Pfizer, the US Court of Appeals for the Federal Circuit has affirmed the validity of a pair of patents covering blood clot treatment, Eliquis.
Biotechnology
Pfizer to collaborate with Imcyse on new immunotherapy programme
5 February 2021   Pfizer has struck a research and licensing agreement with Belgium biopharmaceutical company Imcyse to develop treatments for rheumatoid arthritis using Imotopes - Imcyse’s platform of immunotherapeutics based on synthetic peptides.
Generics
Sigmapharm to appeal Pfizer and BMS’ Eliquis win
3 September 2020   Generics maker Sigmapharm Laboratories is appealing against a court win for Pfizer and Bristol Myers Squibb over patents for blood-thinner Eliquis.

More on this story

Americas
BMS, Pfizer win patent dispute over blockbuster drug, Eliquis
6 September 2021   In a victory for Bristol-Myers Squibb and Pfizer, the US Court of Appeals for the Federal Circuit has affirmed the validity of a pair of patents covering blood clot treatment, Eliquis.
Biotechnology
Pfizer to collaborate with Imcyse on new immunotherapy programme
5 February 2021   Pfizer has struck a research and licensing agreement with Belgium biopharmaceutical company Imcyse to develop treatments for rheumatoid arthritis using Imotopes - Imcyse’s platform of immunotherapeutics based on synthetic peptides.
Generics
Sigmapharm to appeal Pfizer and BMS’ Eliquis win
3 September 2020   Generics maker Sigmapharm Laboratories is appealing against a court win for Pfizer and Bristol Myers Squibb over patents for blood-thinner Eliquis.

More features

Could Apple v Masimo limit patent cases at the ITC?
Eli Lilly strikes again in weight-loss drugs fight
Novartis moves to block cancer drug generic in US
WATCH: China patent landscape—AI, patent linkage, export controls, and more
China bars USPTO employee from leaving country
UPC hands rare default win to Insulet, bans insulin pump in EU
GSK loses appeal over purple inhaler TM in Europe
Astellas defends Xtandi patent as court rejects generics’ appeal